Literature DB >> 15701565

Epilepsy and the immune system: is there a link?

An D Billiau1, Carine H Wouters, Lieven G Lagae.   

Abstract

The concept that the immune system plays a role in the epileptogenic process of some epileptic syndromes was first proposed more than 20 years ago. Since then, numerous studies have reported on the existence of a variety of immunological alterations in epileptic patients, on the observation of favourable responses of refractory epilepsy syndromes to immunomodulatory treatment, and on the association of certain well-known immune-mediated disease states with epilepsy. This review comprehensively recapitulates the currently available evidence supporting or arguing against the possible involvement of the immune system in the pathogenesis of certain types of epilepsy. It is concluded that an abundance of facts is in support of this concept and that further studies should be directed at substantiating the pathogenic significance of (auto)immune responses in certain types of epilepsy. Current progress in the functional and molecular immunological research techniques will indisputably contribute to the elucidation of this link.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15701565     DOI: 10.1016/j.ejpn.2004.10.005

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  7 in total

1.  Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice.

Authors:  Martine M Mirrione; Dorothy K Konomos; Iordanis Gravanis; Stephen L Dewey; Adriano Aguzzi; Frank L Heppner; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2010-04-09       Impact factor: 5.996

Review 2.  Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity.

Authors:  Luca Errichiello; Salvatore Striano; Federico Zara; Pasquale Striano
Journal:  Neurol Sci       Date:  2011-04-06       Impact factor: 3.307

3.  Intavenous immunoglobulin for the management of intractable epilepsy in a boy.

Authors:  E Papadopoulou-Alataki; K Garganis; E Dalpa; S Alataki; M Spilioti
Journal:  Hippokratia       Date:  2017 Jan-Mar       Impact factor: 0.471

4.  Longstanding epileptic encephalopathy and linear localized scleroderma: two distinct pathologic processes in an adolescent.

Authors:  Donato Rigante; Domenica Battaglia; Ilaria Contaldo; Ilaria La Torraca; Laura Avallone; Stefania Gaspari; Giulia Bersani; Achille Stabile
Journal:  Rheumatol Int       Date:  2008-02-16       Impact factor: 2.631

5.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

6.  Intravenous immunoglobulins for epilepsy.

Authors:  JinSong Geng; JianCheng Dong; Youping Li; HengJian Ni; Kui Jiang; Li Li Shi; GuoHua Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-12-02

7.  Tumor necrosis factor-α and interleukin-6 concentrations in cerebrospinal fluid of dogs after seizures.

Authors:  Y Merbl; A Sommer; O Chai; I Aroch; G Zimmerman; A Friedman; H Soreq; M H Shamir
Journal:  J Vet Intern Med       Date:  2014-10-10       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.